drugset
Drugs / Adsorbed COVID-19 (Inactivated) Vaccine
last change Jul 2023 re-read 3 minutes ago

Adsorbed COVID-19 (Inactivated) Vaccine

Vaccine

Developed for
COVID-19
Investigated by
Butantan Institute · Sinovac Life Sciences Co., Ltd.

Trials 2

today NCT04747821 · Ph 4 NCT04456595 · Ph 3
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial · 1 met primary
Phase 3 NCT04456595 Jul → Dec 2020 COVID-19 Butantan Institute Completed Met primary
Phase 41 trial · 1 met primary
Phase 4 NCT04747821 Feb 2021 → Mar 2023 COVID-19 Butantan Institute Completed Met primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Adsorbed COVID-19 (inactivated) Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT04456595 ↗
1

NCT04747821 ↗
Modality Vaccine “Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac” NCT04456595 ↗
Route Intramuscular “two doses intramuscular injections (deltoid)” NCT04456595 ↗